Selected research
Market Structure
Global Pseudouridine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pseudouridine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pseudouridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pseudouridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pseudouridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pseudouridine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pseudouridine include Biosynth Carbosynth, BOC Sciences, Jena Bioscience, MP Biomedicals, Inc, TCI, Toronto Research Chemical, TriLink BioTechnologies, Ulcho Biochemical Ltd (FCAD Group) and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pseudouridine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pseudouridine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pseudouridine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pseudouridine market size, projected growth trends, production technologies, key applications, and end-use industries.
Pseudouridine Segment by Company
Biosynth Carbosynth
BOC Sciences
Jena Bioscience
MP Biomedicals, Inc
TCI
Toronto Research Chemical
TriLink BioTechnologies
Ulcho Biochemical Ltd (FCAD Group)
Thermo Fisher Scientific
YAMASA Corporation
Shanghai Hongene Biotech
Wuhan Finetech
Wuhan Glycogene
Pseudouridine Segment by Type
Powder
Solution
Pseudouridine Segment by Application
Vaccines and Other RNA Medicines
Scientific Research
Pseudouridine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pseudouridine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pseudouridine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pseudouridine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pseudouridine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pseudouridine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pseudouridine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pseudouridine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Solution
Applications
- Vaccines and Other RNA Medicines
- Scientific Research
Companies covered
- Biosynth Carbosynth
- BOC Sciences
- Jena Bioscience
- MP Biomedicals, Inc
- TCI
- Toronto Research Chemical
- TriLink BioTechnologies
- Ulcho Biochemical Ltd (FCAD Group)
- Thermo Fisher Scientific
- YAMASA Corporation
- Shanghai Hongene Biotech
- Wuhan Finetech
- Wuhan Glycogene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pseudouridine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pseudouridine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pseudouridine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pseudouridine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pseudouridine Market Dynamics
- 2.1 Pseudouridine Industry Trends
- 2.2 Pseudouridine Industry Drivers
- 2.3 Pseudouridine Industry Opportunities and Challenges
- 2.4 Pseudouridine Industry Restraints
3 Pseudouridine Market by Manufacturers
- 3.1 Global Pseudouridine Revenue by Manufacturers (2021-2026)
- 3.2 Global Pseudouridine Sales by Manufacturers (2021-2026)
- 3.3 Global Pseudouridine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pseudouridine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pseudouridine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pseudouridine Manufacturers, Product Type & Application
- 3.7 Global Pseudouridine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pseudouridine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pseudouridine Players Market Share by Revenue in 2025
- 3.8.3 2025 Pseudouridine Tier 1, Tier 2, and Tier 3
4 Pseudouridine Market by Type
- 4.1 Pseudouridine Type Introduction
- 4.1.1 Powder
- 4.1.2 Solution
- 4.2 Global Pseudouridine Sales by Type
- 4.2.1 Global Pseudouridine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pseudouridine Sales by Type (2021-2032)
- 4.2.3 Global Pseudouridine Sales Market Share by Type (2021-2032)
- 4.3 Global Pseudouridine Revenue by Type
- 4.3.1 Global Pseudouridine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pseudouridine Revenue by Type (2021-2032)
- 4.3.3 Global Pseudouridine Revenue Market Share by Type (2021-2032)
5 Pseudouridine Market by Application
- 5.1 Pseudouridine Application Introduction
- 5.1.1 Vaccines and Other RNA Medicines
- 5.1.2 Scientific Research
- 5.2 Global Pseudouridine Sales by Application
- 5.2.1 Global Pseudouridine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pseudouridine Sales by Application (2021-2032)
- 5.2.3 Global Pseudouridine Sales Market Share by Application (2021-2032)
- 5.3 Global Pseudouridine Revenue by Application
- 5.3.1 Global Pseudouridine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pseudouridine Revenue by Application (2021-2032)
- 5.3.3 Global Pseudouridine Revenue Market Share by Application (2021-2032)
6 Global Pseudouridine Sales by Region
- 6.1 Global Pseudouridine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pseudouridine Sales by Region (2021-2032)
- 6.2.1 Global Pseudouridine Sales by Region (2021-2026)
- 6.2.2 Global Pseudouridine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pseudouridine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pseudouridine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pseudouridine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pseudouridine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pseudouridine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pseudouridine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pseudouridine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pseudouridine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pseudouridine Revenue by Region
- 7.1 Global Pseudouridine Revenue by Region
- 7.1.1 Global Pseudouridine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pseudouridine Revenue by Region (2021-2026)
- 7.1.3 Global Pseudouridine Revenue by Region (2027-2032)
- 7.1.4 Global Pseudouridine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pseudouridine Revenue (2021-2032)
- 7.2.2 North America Pseudouridine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pseudouridine Revenue (2021-2032)
- 7.3.2 Europe Pseudouridine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pseudouridine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pseudouridine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pseudouridine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pseudouridine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Biosynth Carbosynth
- 8.1.1 Biosynth Carbosynth Company Information
- 8.1.2 Biosynth Carbosynth Business Overview
- 8.1.3 Biosynth Carbosynth Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Biosynth Carbosynth Pseudouridine Product Portfolio
- 8.1.5 Biosynth Carbosynth Recent Developments
- 8.2 BOC Sciences
- 8.2.1 BOC Sciences Company Information
- 8.2.2 BOC Sciences Business Overview
- 8.2.3 BOC Sciences Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BOC Sciences Pseudouridine Product Portfolio
- 8.2.5 BOC Sciences Recent Developments
- 8.3 Jena Bioscience
- 8.3.1 Jena Bioscience Company Information
- 8.3.2 Jena Bioscience Business Overview
- 8.3.3 Jena Bioscience Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Jena Bioscience Pseudouridine Product Portfolio
- 8.3.5 Jena Bioscience Recent Developments
- 8.4 MP Biomedicals, Inc
- 8.4.1 MP Biomedicals, Inc Company Information
- 8.4.2 MP Biomedicals, Inc Business Overview
- 8.4.3 MP Biomedicals, Inc Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 MP Biomedicals, Inc Pseudouridine Product Portfolio
- 8.4.5 MP Biomedicals, Inc Recent Developments
- 8.5 TCI
- 8.5.1 TCI Company Information
- 8.5.2 TCI Business Overview
- 8.5.3 TCI Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 TCI Pseudouridine Product Portfolio
- 8.5.5 TCI Recent Developments
- 8.6 Toronto Research Chemical
- 8.6.1 Toronto Research Chemical Company Information
- 8.6.2 Toronto Research Chemical Business Overview
- 8.6.3 Toronto Research Chemical Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Toronto Research Chemical Pseudouridine Product Portfolio
- 8.6.5 Toronto Research Chemical Recent Developments
- 8.7 TriLink BioTechnologies
- 8.7.1 TriLink BioTechnologies Company Information
- 8.7.2 TriLink BioTechnologies Business Overview
- 8.7.3 TriLink BioTechnologies Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 TriLink BioTechnologies Pseudouridine Product Portfolio
- 8.7.5 TriLink BioTechnologies Recent Developments
- 8.8 Ulcho Biochemical Ltd (FCAD Group)
- 8.8.1 Ulcho Biochemical Ltd (FCAD Group) Company Information
- 8.8.2 Ulcho Biochemical Ltd (FCAD Group) Business Overview
- 8.8.3 Ulcho Biochemical Ltd (FCAD Group) Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Ulcho Biochemical Ltd (FCAD Group) Pseudouridine Product Portfolio
- 8.8.5 Ulcho Biochemical Ltd (FCAD Group) Recent Developments
- 8.9 Thermo Fisher Scientific
- 8.9.1 Thermo Fisher Scientific Company Information
- 8.9.2 Thermo Fisher Scientific Business Overview
- 8.9.3 Thermo Fisher Scientific Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Thermo Fisher Scientific Pseudouridine Product Portfolio
- 8.9.5 Thermo Fisher Scientific Recent Developments
- 8.10 YAMASA Corporation
- 8.10.1 YAMASA Corporation Company Information
- 8.10.2 YAMASA Corporation Business Overview
- 8.10.3 YAMASA Corporation Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 YAMASA Corporation Pseudouridine Product Portfolio
- 8.10.5 YAMASA Corporation Recent Developments
- 8.11 Shanghai Hongene Biotech
- 8.11.1 Shanghai Hongene Biotech Company Information
- 8.11.2 Shanghai Hongene Biotech Business Overview
- 8.11.3 Shanghai Hongene Biotech Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Shanghai Hongene Biotech Pseudouridine Product Portfolio
- 8.11.5 Shanghai Hongene Biotech Recent Developments
- 8.12 Wuhan Finetech
- 8.12.1 Wuhan Finetech Company Information
- 8.12.2 Wuhan Finetech Business Overview
- 8.12.3 Wuhan Finetech Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Wuhan Finetech Pseudouridine Product Portfolio
- 8.12.5 Wuhan Finetech Recent Developments
- 8.13 Wuhan Glycogene
- 8.13.1 Wuhan Glycogene Company Information
- 8.13.2 Wuhan Glycogene Business Overview
- 8.13.3 Wuhan Glycogene Pseudouridine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Wuhan Glycogene Pseudouridine Product Portfolio
- 8.13.5 Wuhan Glycogene Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pseudouridine Value Chain Analysis
- 9.1.1 Pseudouridine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pseudouridine Production Mode & Process
- 9.2 Pseudouridine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pseudouridine Distributors
- 9.2.3 Pseudouridine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst